Home/Filings/4/0001610717-25-000115
4//SEC Filing

MILLER RICHARD A MD 4

Accession 0001610717-25-000115

CIK 0001626971other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 4:09 PM ET

Size

7.7 KB

Accession

0001610717-25-000115

Insider Transaction Report

Form 4
Period: 2025-05-07
MILLER RICHARD A MD
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Warrant (Right to Buy)

    2025-05-07559,0730 total
    Exercise: $3.50From: 2024-05-06Exp: 2025-06-30Common Stock (559,073 underlying)
  • Exercise/Conversion

    Common Stock

    2025-05-07$3.50/sh+559,073$1,956,7561,136,707 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,188,103
Footnotes (2)
  • [F1]These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
  • [F2]Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312.

Documents

1 file

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001031847

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:09 PM ET
Size
7.7 KB